These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 29049612)

  • 1. Long-term Change in the Risk of Skin Cancer After Organ Transplantation: A Population-Based Nationwide Cohort Study.
    Rizvi SMH; Aagnes B; Holdaas H; Gude E; Boberg KM; Bjørtuft Ø; Helsing P; Leivestad T; Møller B; Gjersvik P
    JAMA Dermatol; 2017 Dec; 153(12):1270-1277. PubMed ID: 29049612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
    Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
    Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US.
    Sargen MR; Cahoon EK; Yu KJ; Madeleine MM; Zeng Y; Rees JR; Lynch CF; Engels EA
    JAMA Dermatol; 2022 Apr; 158(4):414-425. PubMed ID: 35262623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study.
    Krynitz B; Edgren G; Lindelöf B; Baecklund E; Brattström C; Wilczek H; Smedby KE
    Int J Cancer; 2013 Mar; 132(6):1429-38. PubMed ID: 22886725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
    Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
    JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens.
    Jensen P; Hansen S; Møller B; Leivestad T; Pfeffer P; Geiran O; Fauchald P; Simonsen S
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):177-86. PubMed ID: 10025742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States.
    Garrett GL; Blanc PD; Boscardin J; Lloyd AA; Ahmed RL; Anthony T; Bibee K; Breithaupt A; Cannon J; Chen A; Cheng JY; Chiesa-Fuxench Z; Colegio OR; Curiel-Lewandrowski C; Del Guzzo CA; Disse M; Dowd M; Eilers R; Ortiz AE; Morris C; Golden SK; Graves MS; Griffin JR; Hopkins RS; Huang CC; Bae GH; Jambusaria A; Jennings TA; Jiang SI; Karia PS; Khetarpal S; Kim C; Klintmalm G; Konicke K; Koyfman SA; Lam C; Lee P; Leitenberger JJ; Loh T; Lowenstein S; Madankumar R; Moreau JF; Nijhawan RI; Ochoa S; Olasz EB; Otchere E; Otley C; Oulton J; Patel PH; Patel VA; Prabhu AV; Pugliano-Mauro M; Schmults CD; Schram S; Shih AF; Shin T; Soon S; Soriano T; Srivastava D; Stein JA; Sternhell-Blackwell K; Taylor S; Vidimos A; Wu P; Zajdel N; Zelac D; Arron ST
    JAMA Dermatol; 2017 Mar; 153(3):296-303. PubMed ID: 28097368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark.
    Jensen AO; Svaerke C; Farkas D; Pedersen L; Kragballe K; Sørensen HT
    Acta Derm Venereol; 2010 Sep; 90(5):474-9. PubMed ID: 20814621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017.
    Sargen MR; Cahoon EK; Lynch CF; Tucker MA; Goldstein AM; Engels EA
    JAMA Dermatol; 2020 Dec; 156(12):1307-1314. PubMed ID: 33146669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
    Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
    Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Kaposi sarcoma after solid organ transplantation in the United States.
    Cahoon EK; Linet MS; Clarke CA; Pawlish KS; Engels EA; Pfeiffer RM
    Int J Cancer; 2018 Dec; 143(11):2741-2748. PubMed ID: 29987894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study).
    Stenz NA; Stampf S; Arnold AW; Cozzio A; Dickenmann M; Gaide O; Harms M; Hunger RE; Laffitte E; Mühlstädt M; Nägeli M; Hofbauer GFL;
    Dermatology; 2021; 237(6):970-980. PubMed ID: 33227788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers.
    Zamoiski RD; Yanik E; Gibson TM; Cahoon EK; Madeleine MM; Lynch CF; Gustafson S; Goodman MT; Skeans M; Israni AK; Engels EA; Morton LM
    Cancer Res; 2017 Aug; 77(15):4196-4203. PubMed ID: 28615224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Rare Cancers Among Solid Organ Transplant Recipients.
    D'Arcy ME; Castenson D; Lynch CF; Kahn AR; Morton LM; Shiels MS; Pfeiffer RM; Engels EA
    J Natl Cancer Inst; 2021 Feb; 113(2):199-207. PubMed ID: 32462187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HLA Antigen Mismatch With Risk of Developing Skin Cancer After Solid-Organ Transplant.
    Gao Y; Twigg AR; Hirose R; Roll GR; Nowacki AS; Maytin EV; Vidimos AT; Rajalingam R; Arron ST
    JAMA Dermatol; 2019 Mar; 155(3):307-314. PubMed ID: 30673077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin Cancer Development Is Strongly Associated with Actinic Keratosis in Solid Organ Transplant Recipients: A Danish Cohort Study.
    Wenande E; Togsverd-Bo K; Hastrup A; Lei U; Philipsen PA; Haedersdal M
    Dermatology; 2023; 239(3):393-402. PubMed ID: 36731451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs).
    Asgari MM; Arron ST; Warton EM; Quesenberry CP; Weisshaar D
    J Am Acad Dermatol; 2015 Sep; 73(3):444-50. PubMed ID: 26138646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer.
    Karia PS; Azzi JR; Heher EC; Hills VM; Schmults CD
    JAMA Dermatol; 2016 May; 152(5):533-40. PubMed ID: 26792250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management.
    Berg D; Otley CC
    J Am Acad Dermatol; 2002 Jul; 47(1):1-17; quiz 18-20. PubMed ID: 12077575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients.
    Cheng JY; Li FY; Ko CJ; Colegio OR
    JAMA Dermatol; 2018 Jan; 154(1):60-66. PubMed ID: 29167858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.